A new small scale study reveals the antidepressant fluvoxamine may be a new tool in the fight against COVID-19. Researchers report fluvoxamine reduced the severity of coronavirus symptoms and hospitalizations.
from Neuroscience News https://ift.tt/3ptD1yo
Comments
Post a Comment